DiscoverThe Simple BioTech Podcast#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy
#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Update: 2020-11-12
Share

Description

Imagine if you could turn the characteristics of a cell on and off… or up and down like a volume trigger… constantly tuning things until everything is working just right. It might sound impossible, but that’s exactly what Obsidian therapeutics is working on.

I’ll admit, it was tough for me to wrap my mind around this one at first, but my guest today did a fantastic job of explaining things. So without further ado, chief development officer of Obsidian therapeutics, Catherine Stehman-Breen.

Podcast notes and transcript available here: https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics

-James Ruhle, SimpleBioTechPodcast.com

Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech

If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

Comments 
In Channel
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

James Ruhle